Pacira BioSciences (PCRX) Cost of Revenue (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Cost of Revenue of $36.4 million for Q1 2026, up 6.14% year-over-year from $34.3 million in Q1 2025, and down 9.64% quarter-over-quarter from $40.3 million in Q4 2025.
Pacira BioSciences (PCRX) Cost of Revenue (2010 - 2026) Analysis & Trends
Pacira BioSciences' Cost of Revenue history runs 17 years deep, the most recent figure standing at $36.4 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 6.14% year-over-year to $36.4 million; the TTM figure through Mar 2026 stood at $151.9 million (down 3.47% YoY), while the FY2025 annual figure was $149.7 million, down 12.13% from the prior year.
- Cost of Revenue for Q1 2026 stood at $36.4 million, down from $40.3 million in the prior quarter.
- The five-year high for Cost of Revenue was $61.9 million in Q4 2022, with the low at $34.3 million in Q3 2025.
- The 5-year median for Cost of Revenue is $40.9 million (2025), against an average of $43.6 million.
- The sharpest annual moves came in 2022 and 2025: Cost of Revenue surged 58.73% in 2022, then decreased 27.65% in 2025.
- Pacira BioSciences' Cost of Revenue stood at $61.9 million in 2022, then decreased by 22.97% to $47.7 million in 2023, then declined by 16.37% to $39.9 million in 2024, then advanced by 1.04% to $40.3 million in 2025, then dropped by 9.64% to $36.4 million in 2026.
- Business Quant data shows PCRX's Cost of Revenue at $36.4 million in Q1 2026, $40.3 million in Q4 2025, and $34.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Pacira BioSciences | 945.90 Mn | 694.87 Mn | 148.24 Mn | 44.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.16 Mn |
| Jun 30, 2026 | 44.16 Mn |
| Mar 31, 2026 | 36.41 Mn |
| Mar 31, 2026 | 36.41 Mn |
| Dec 31, 2025 | 40.30 Mn |
| Dec 31, 2025 | 40.30 Mn |
| Sep 30, 2025 | 34.28 Mn |
| Sep 30, 2025 | 34.28 Mn |
| Jun 30, 2025 | 40.87 Mn |
| Jun 30, 2025 | 40.87 Mn |
| Mar 31, 2025 | 34.31 Mn |
| Mar 31, 2025 | 34.31 Mn |
| Dec 31, 2024 | 39.89 Mn |
| Dec 31, 2024 | 39.89 Mn |
| Sep 30, 2024 | 38.86 Mn |
| Sep 30, 2024 | 38.86 Mn |
| Jun 30, 2024 | 44.26 Mn |
| Jun 30, 2024 | 44.26 Mn |
| Mar 31, 2024 | 47.42 Mn |
| Mar 31, 2024 | 47.42 Mn |